Statin Adverse Reaction
20
5
5
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
10.0%
2 terminated out of 20 trials
80.0%
-6.5% vs benchmark
65%
13 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
Exercise Intensity and Muscle Recovery in Statin Users
Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
DESIFOR-EXPAND (MHIF)
Hepatic Safety of Statin Use in Neurology Inpatients
Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
The Association of Statins on Cardiorespiratory Fitness and Exercise Adaptation
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events
Medicines Gaps Study
MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
NIRS to Diagnose SAMS
MUscle Side-Effects of Atorvastatin in Coronary Patients
Statin Intolerance in Patients With Myocardial Infarction
Quality of Life in Patients With Statin-Associated Myopathy